Mark Muscat

Summary

Publications

  1. doi Toward rubella elimination in Europe: an epidemiological assessment
    Mark Muscat
    EUVAC NET hub, Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    Vaccine 30:1999-2007. 2012
  2. doi Who gets measles in Europe?
    Mark Muscat
    Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    J Infect Dis 204:S353-65. 2011
  3. doi Measles in Europe: an epidemiological assessment
    Mark Muscat
    EUVAC NET hub, Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    Lancet 373:383-9. 2009
  4. ncbi Decline in measles in WHO European Region but rubella remains high
    Mark Muscat
    Statens Serum Institut, Copenhagen, Denmark
    Euro Surveill 10:E050324.3. 2005
  5. ncbi The benefit of molecular characterization during a measles upsurge in Denmark
    Mark Muscat
    Department of Epidemiology, Statens Serum Institut, Artillerivej 5, DK 2300 Copenhagen S, Denmark
    Vaccine 25:6232-6. 2007
  6. doi Invasive meningococcal disease in Malta: an epidemiological overview, 1994-2007
    Mark Muscat
    Department of Epidemiology, Statens Serum Institut, Artillerivej 5, DK 2300 Copenhagen S, Denmark
    J Med Microbiol 58:1492-8. 2009

Detail Information

Publications6

  1. doi Toward rubella elimination in Europe: an epidemiological assessment
    Mark Muscat
    EUVAC NET hub, Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    Vaccine 30:1999-2007. 2012
    ..The elimination of rubella and prevention of congenital rubella syndrome (CRS) by 2015 are established goals for Europe. Our aim was to review the epidemiology of rubella in relation to this goal...
  2. doi Who gets measles in Europe?
    Mark Muscat
    Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    J Infect Dis 204:S353-65. 2011
    ..This article aims to describe individuals susceptible to measles, and provide an overview of affected groups and the public settings in which measles transmission occurred in Europe in 2005-2009...
  3. doi Measles in Europe: an epidemiological assessment
    Mark Muscat
    EUVAC NET hub, Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark
    Lancet 373:383-9. 2009
    ..Our aim was therefore to review the epidemiology of measles in relation to the goal of elimination by 2010...
  4. ncbi Decline in measles in WHO European Region but rubella remains high
    Mark Muscat
    Statens Serum Institut, Copenhagen, Denmark
    Euro Surveill 10:E050324.3. 2005
  5. ncbi The benefit of molecular characterization during a measles upsurge in Denmark
    Mark Muscat
    Department of Epidemiology, Statens Serum Institut, Artillerivej 5, DK 2300 Copenhagen S, Denmark
    Vaccine 25:6232-6. 2007
    ..Molecular epidemiological studies have proved to be both a useful and a necessary component of an enhanced surveillance system required in the measles elimination phase...
  6. doi Invasive meningococcal disease in Malta: an epidemiological overview, 1994-2007
    Mark Muscat
    Department of Epidemiology, Statens Serum Institut, Artillerivej 5, DK 2300 Copenhagen S, Denmark
    J Med Microbiol 58:1492-8. 2009
    ..Until vaccines against a broad range of serogroup B meningococci become available for universal use, the main methods of control remain the early treatment of cases and the prevention of secondary cases...